Drug Profile
Hib vaccine - Human Genome Sciences/AstraZeneca
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Human Genome Sciences; MedImmune
- Class Haemophilus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Haemophilus infections
Most Recent Events
- 04 Oct 2004 Discontinued - Preclinical for Haemophilus infections in USA (unspecified route)
- 19 Jan 2000 Suspended-Preclinical for Haemophilus infections in USA (Unknown route)
- 03 Jan 1996 Preclinical development for Haemophilus infections in USA (Unknown route)